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Abstract
Transport of thyroxine (T4) into the liver is inhibited in
fasting and by bilirubin, a compound often accumulating
in the serum of critically ill patients. We tested the effects
of chronic and acute energy deprivation, bilirubin and its
precursor biliverdin on the 15-min uptake of [125I]tri-
iodothyronine ([125I]T3) and [
125I]T4 and on TSH release
in rat anterior pituitary cells maintained in primary culture
for 3 days. When cells were cultured and incubated in
medium without glucose and glutamine to induce chronic
energy deprivation, the ATP content was reduced by 45%
(P<0·05) and [125I]T3 uptake by 13% (NS), but TSH
release was unaltered. Preincubation (30 min) and incu-
bation (15 min) with 10 µM oligomycin reduced ATP
content by 51% (P<0·05) and 53% (P<0·05) under
energy-rich and energy-poor culture conditions respect-
ively; [125I]T3 uptake was reduced by 66% (P<0·05)
and 64% (P<0·05). Neither bilirubin nor biliverdin
(both 1–200 µM) affected uptake of [125I]T3 or [
125I]T4.
Bilirubin (1–50 µM) did not alter basal or TRH-induced
TSH release. In conclusion, the absence of inhibitory
effects of chronic energy deprivation and bilirubin on
thyroid hormone uptake by pituitary cells supports the
view that the transport is regulated differently than that in
the liver.
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Introduction
Non-thyroidal illness (NTI) is associated with multiple
alterations in serum thyroid hormone parameters. Most
prominent are the low serum tri-iodothyronine (T3) and
increased reverse T3 concentrations, together with in-
appropriately low concentrations of serum thyroid-
stimulating hormone (TSH) (Wartofsky & Burman 1982,
Docter et al. 1993). Apart from fasting, conditions that may
result in NTI include chronic renal failure and liver disease
(Wartofsky & Burman 1982, Kaptein 1996).
As the liver is the major site of T3 production in humans
(Hennemann 1986), the low serum T3 during NTI can be
ascribed to a reduced type I deiodinase activity (Harris
et al. 1978, Kohrle et al. 1991), in addition to a reduced
transport of thyroxine (T4) into the liver (De Jong et al.
1992, 1994, Vos et al. 1995). The diminished tissue uptake
of T4 in calorie-deprived humans (Van Der Heyden et al.
1986) seems to be secondary to the reduction in cellular
ATP (De Jong et al. 1994). The reduction in T4 transport
into the liver in chronic renal failure or liver disease can
be explained by inhibitory effects of compounds that
accumulate in the serum, such as furan fatty acids, indoxyl
sulphate or bilirubin (Lim et al. 1993a, b). Conversely,
despite the observed alterations in serum thyroid hormone
parameters in NTI, there is no change in expression
of T3-regulated genes in the liver, indicating the
maintenance of tissue euthyroidism (Chamba et al. 1996).
Because serum TSH does not increase, in spite of the
low serum T3 in fasting or NTI, we suggested in a
previous study that T3 transport into the pituitary is
regulated differently from that in liver (Everts et al. 1996).
Indeed, in contrast to the effects on T4 transport observed
in hepatocytes (Lim et al. 1993a), the furan fatty
acid 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid
(CMPF) and indoxyl sulphate – compounds accumulating
in serum of patients with chronic renal failure – did not
affect uptake of T3 and T4 into pituitary cells (Everts et al.
1995a).
This hypothesis was further elaborated in the present
study. We have investigated the effects of chronic energy
deprivation and bilirubin – a compound often accumulat-
ing in serum of patients with liver disease (Lim et al.
1993b) – and its precursor, biliverdin, on the uptake of T3
and T4 and on basal and thyrotrophin-releasing hormone
(TRH)-stimulated TSH release in cultured anterior pitui-
tary cells. To induce chronic energy deprivation, we
cultured anterior pituitary cells from fed rats in medium
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lacking glucose and glutamine. The effects of bilirubin
and its precursor biliverdin were tested by adding the
compounds to the incubation medium at concentrations
(relative to albumin) in the range from those present in
normal serum to greater than those present in serum of
patients with liver disease.
Materials and Methods
Animals
All experiments were performed using male Wistar rats,
weighing 200–220 g. The animals had free access to food
and water and were kept in a controlled environment
(21 C) with constant day length (12 h).
Pituitary cell culture
Animals (12–16 for each experiment) were killed between
0900 and 0930 h by decapitation. The pituitary glands
were removed within 5 min, the neurointermediate lobe
was discarded, and the anterior lobes were collected
in calcium- and magnesium-free Hank’s Balanced Salt
Solution, supplemented with 10 g/l human serum
albumin, penicillin (105 U/l), amphotericin B (0·5 mg/l),
and sodium bicarbonate (0·4 g/l). Anterior pituitary cells
were dissociated with dispase (final concentration
2·4103 U/l), as previously described (Everts et al. 1993,
1994a). From each pituitary, 1–2106 cells were
obtained and the viability of the cells as determined by
trypan blue exclusion was greater than 90%.
The cells were cultured at 37 C in a water-jacketed
incubator with 5% CO2 at a density of approximately
5105 cells/well in 48-well culture dishes. The cells had
attached to the wells after 2 days of culture. On day 3, the
cells were used for experiments. The culture medium
consisted of Minimal Essential Medium with Earle’s salts
(MEM) supplemented with non-essential amino acids,
sodium pyruvate (1 mM), 10% fetal calf serum, penicillin
(105 U/l), amphotericin B (0·5 mg/l), glucose (6·25 mM),
-glutamine (2 mM) and sodium bicarbonate (2·2 g/l
pH 7·4) (Everts et al. 1993, 1994a). For culture under
energy-poor conditions, the culture medium was based on
MEM without glucose, supplemented with non-essential
amino acids, sodium pyruvate (1 mM), 10% fetal calf
serum, penicillin (105 U/l), amphotericin B (0·5 mg/l)
and sodium bicarbonate (2·2 g/l pH 7·4).
Cellular uptake of [125I]T3 and [
125I]T4
Cellular uptake experiments were performed as described
previously (Everts et al. 1993, 1994a). Briefly, cells
were cultured for 3 days at a density of approximately
500 000 cells/well. Blank wells contained only culture
medium. The culture medium was removed and cells
were preincubated in incubation medium. This medium
was identical to the culture medium, except that the fetal
calf serum was replaced by 0·5% BSA when [125I]T3
(50 000 c.p.m.; 50 pM) was measured, and by 0·1%
BSA in case of [125I]T4 (100 000 c.p.m.; 175 pM)
uptake. Furthermore, NaHCO3 (25 mM) was replaced
by N-2-hydroxyethyl-piperazine-N-2-ethanesulphonic
acid (HEPES 8·9 mM), piperazine-N,N-bis(2-ethane-
sulphonic acid) (PIPES 10·6 mM), and N,N-bis(2-
hydroxyethyl)-2-aminoethane-sulphonic acid (BES
11·2 mM). To study the effects of acute ATP depletion on
[125I]T3 uptake, we carried out preincubation (0·5 ml) for
30 min in the absence or presence of oligomycin (10 µM),
then the preincubation medium was discarded and cells
were incubated for 15 min in 0·25 ml medium containing
[125I]T3 without or with 10 µM oligomycin. Both pre-
incubation and incubation were performed in a 37 C
incubation chamber on a rotating device. Experiments to
test the effects of bilirubin (1–200 µM) and biliverdin
(1–200 µM) on [125I]T3 and [
125I]T4 uptake were per-
formed as described above, except that, after preincubation
(0·25 ml, 30 min) without or with bilirubin or biliverdin,
incubation was started by the addition of 10 µl [125I]T3 or
[125I]T4 directly to the wells.
After incubation, the medium was removed and cells
were washed once with 1 ml ice-cold saline in order to
remove unbound tracer. Cells were dissolved in 1 ml
0·1 M NaOH and were counted for iodine-125 activity
in a 16-channel gamma-counter (NE 1600, Nuclear
Enterprises, Edinburgh, Scotland). The amount of [125I]T3
or [125I]T4 taken up by the cells was expressed as a
percentage of the total radioactivity added (percentage
dose). The procedure described above was also applied to
incubations without cells. All results were corrected for
radioactivity retained in the blanks.
TSH release and cellular content
The culture medium was removed, centrifuged (2000g)
and frozen until required for hormone determination. The
incubation medium was identical to the culture medium,
except that the fetal calf serum was replaced by 0·5% BSA.
Cells were preincubated for 2 h in the absence or presence
of bilirubin (1–200 µM). Thereafter, this medium was dis-
carded and cells were incubated for 2 h with the same
concentrations bilirubin without or with TRH (100 nM).
After incubation, the medium was removed, centrifuged
(2000g) and stored at20 C.
To determine the TSH content of the cells, 0·5 ml
incubation medium was added to the wells. The cells were
scraped from the wells with a rubber policeman and the
wells were sonicated for 230 s. The extracts were
removed and the wells were washed with 0·5 ml medium.
The two fractions were combined (volume of cell extract
1·0 ml), centrifuged (2000g) at room temperature and
the supernatant was frozen until further analysis.
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TSH determination
TSH in incubation media and cell extracts was measured
by RIA (Everts et al. 1993). Addition of bilirubin (5 and
200 µM) to the TSH standards did not alter the standard
curve.
Free hormone concentration
Calculation of the free T3 (fT3) or free T4 (fT4) concen-
trations was based on determination of the free hormone
fractions by equilibrium dialysis (Sterling & Brenner
1966). As shown previously (Everts et al. 1993), the fT3
fraction was not altered by 10 µM T3 or oligomycin.
ATP and DNA determination
The cellular ATP content was determined in perchloric
acid (0·2 M) extracts with the Lumac AEC Kit (Lumac,
Landgraaf, The Netherlands). The DNA content of the
cells was determined using a modification (Everts et al.
1994a) of the fluorescence technique described by Downs
& Wilfinger (1983).
Chemicals and isotopes
All solutions used for cell isolation and cell culture were
obtained from GIBCO Europe (Breda, The Netherlands),
with the exception of human serum albumin (Central
Laboratory of the Red Cross Blood Transfusion Service,
Amsterdam, The Netherlands), dispase (grade II;
Boehringer, Mannheim, Germany) and amphotericin
B (Fungizone, Bristol-Myers Squibb, Woerden, The
Netherlands). Culture dishes (48 wells) were from Costar
(Cambridge, MA, USA). PIPES, HEPES, BES, BSA
(fraction V), oligomycin, bilirubin and biliverdin were all
from Sigma (St Louis, MO, USA). -T3 (T3) was from
Henning Berlin Gmbh (Berlin, Germany) and TRH was
from Hoechst AG (Frankfurt am Main, Germany).
[3,5-125I]T4 (1500 µCi/µg) and [3-
125I]T3 (3070 µCi/
µg) were obtained from Amersham International
(Aylesbury, Bucks, UK). Reagents for the rat TSH RIA
were kindly provided by the NIDDK (Bethesda, MD,
USA). Sephadex LH-20 and G-25 were from Pharmacia
(Uppsala, Sweden). All other reagents were of the highest
purity available.
Statistics
Results are presented as means.. The statistical sig-
nificance of the effects of the compounds tested and of
glucose deprivation on TSH release, [125I]T3 and [
125I]T4
uptake, fT3 and fT4 fractions, and cellular ATP and DNA
content was evaluated by Student’s t-test for unpaired
observations or by one-way analysis of variance and
Duncan’s test for a repeated measure design. Differences
were considered significant at P<0·05.
Results
Effects of energy deprivation
Culture of pituitary cells for 3 days without glucose and
glutamine did not affect TSH release (22·440·85 ng,
n=44, compared with 22·601·11 ng, n=44). However,
the cellular ATP content was reduced by 45% (P<0·05)
compared with that in cells cultured in the normal culture
medium (Table 1).
As further shown in Table 1, chronic energy depri-
vation did not alter the 15-min uptake of [125I]T3.
Exposure to 10 µM unlabelled T3 significantly reduced
[125I]T3 uptake under both normal (49%; P<0·05) and
energy-poor (57%; P<0·05) culture conditions. Chronic
Table 1 Effects of chronic or acute energy depletion on ATP content, [125I]T3 uptake and DNA content of anterior pituitary cells
ATP content
(g/well)
[125I]T3 uptake
(% dose/well)
DNA content
(ng/well)
[125I]T3 uptake
(% dose/g DNA)
Experimental conditions
Normal culture conditions
Controls 0·4950·031 (9) 1·490·07 (12) 247535 (3) 0·600·03 (12)
+10 M T3 0·4310·027 (8) 0·760·06 (12)* 2476158 (3) 0·310·02 (12)*
+10 M oligo 0·2440·042 (9)* 0·510·08 (12)* 2791165 (3) 0·180·03 (12)*
Culture without glucose and glutamine
Controls 0·2720·013 (6)† 1·290·07 (12) 213399 (3)† 0·610·03 (12)
+10 M T3 0·2910·034 (8)† 0·550·05 (12)*† 201459 (3) 0·270·03 (12)*
+10 M oligo 0·1280·064 (9) 0·470·14 (12)* 171859 (3)*† 0·270·08 (12)*
Data represent the meansS.E. (number of observations). ATP content and [125I]T3 uptake were measured in three or four experiments and DNA content in
one experiment. Fifty percent of the anterior pituitary cells (500 000 cells/well) were cultured for 3 days in medium containing 10% fetal calf serum (normal
culture conditions) and 50% were cultured in medium lacking glucose and glutamine but with 10% fetal calf serum. Cells were preincubated (30 min) in the
absence or presence of oligomycin (oligo), and incubation (15 min) was performed with [125I]T3 without or with 10 M T3 or oligomycin. *P<0·05 compared
with respective controls; †P<0·05 compared with normal culture conditions.
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energy deprivation only slightly affected the DNA content
of the wells. When [125I]T3 uptake was expressed per µg
DNA, the uptake values for normal and energy-deprived
cells were precisely the same.
Preincubation (30 min) and incubation (15 min) with
10 µM oligomycin reduced the cellular ATP content by
51% (P<0·05) when added under energy-rich culture
conditions and by 53% (P<0·05) when the conditions
were energy-poor. This was associated with significant
reductions in [125I]T3 transport: of 66% (P<0·05) and
64% (P<0·05) respectively (Table 1). Under energy-poor
culture conditions only, oligomycin slightly reduced the
DNA concentrations (Table 1).
Effects of bilirubin and biliverdin
Free hormone fraction The fT3 and fT4 fractions were
determined in medium with 0·5% and 0·1% BSA, respect-
ively. The added concentrations of the compounds were
expressed relative to albumin (molar ratios of from 0·06
to 2·40) because bilirubin and biliverdin both bind to
albumin. The fT3 fraction was 3·570·07% (n=8), and
the fT4 fraction was 3·390·26% (n=8) – values in good
agreement with previous findings (Everts et al. 1995a).
Greater concentrations of bilirubin had no effect on the
fT3 fraction, whereas the fT4 fraction was increased at
bilirubin:albumin ratios of 0·60 and 2·40 respectively
(Fig. 1a). In contrast, biliverdin did not affect the fT3 or
the fT4 fraction (Fig. 1b).
[125I]T3 and [
125I]T4 uptake The effects of bilirubin
and biliverdin on plasma membrane uptake of [125I]T3 and
[125I]T4 were determined in short-term incubations
(15 min). Neither the uptake of [125I]T3 nor that of
[125I]T4, both expressed per pM free hormone, were
altered in presence of bilirubin (Fig. 2a). The effect of
biliverdin on [125I]T3 and [
125I]T4 uptake was determined
in a similar way. The uptake of the two tracers was not
altered by biliverdin (Fig. 2b).
Basal TSH release The effect of bilirubin on basal TSH
release was tested in experiments with 2 h preincubation,
followed by 2 h incubation. The results of the incubation
period are shown in Fig. 3, in which data are expressed as
percentages of the control value. The concentrations of
bilirubin tested (1, 5, 50 and 200 µM) correspond to molar
ratios with albumin of 0·01, 0·06, 0·60 and 2·40 respect-
ively. The lower bilirubin concentrations (1–50 µM) did
not affect basal TSH release, but 200 µM bilirubin resulted
in a significant increase (38%; P<0·05). DNA content
after 4 h of incubation with 200 µM bilirubin was signifi-
cantly lower than that of the controls (1·310·03 µg
DNA/well, n=3, compared with 1·800·05 µg DNA/
well, n=6, respectively; P<0·001).
TRH-induced TSH release The effect of bilirubin on
TRH-induced TSH release was determined during
short (2 h) exposure to TRH after preincubation for
2 h without or with bilirubin (5–200 µM) (Table 2).
Incubation with TRH alone stimulated TSH release by
200% (P<0·05). TRH-induced TSH release was not
altered significantly by the lower bilirubin concentrations
(5–50 µM), but 200 µM bilirubin produced a large
increase (P<0·05; n=6). Cellular TSH content was not
altered after addition of TRH and 5 or 50 µM bilirubin,
but in the presence of 200 µM bilirubin a significant
decline was observed. The total TSH content showed no
significant change with any of the additions.
Figure 1 Effects of bilirubin (a) and biliverdin (b) on the fT3 ()
and fT4 (M) fractions, determined in medium with 0·5% BSA for
[125I]T3 and with 0·1% BSA for [
125I]T4. The fT3 and fT4 fractions
were determined by equilibrium dialysis. The added bilirubin and
biliverdin concentrations are expressed relative to albumin
(bilirubin:albumin ratio). Bars show the mean of four observations
from two experiments. *P<0·05 compared with no additions.
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Discussion
We have previously evaluated the role of the liver and
pituitary in the maintenance of the low serum T3 and
normal TSH concentrations in NTI and fasting (Everts
et al. 1996). In that review, we postulated that the plasma
membrane thyroid hormone transport mechanism is regu-
lated differently in these two tissues, and we provided
experimental evidence for this idea from both in vivo and
in vitro experiments. The hypothesis is further elaborated
in the present study on thyroid hormone transport in
cultured rat anterior pituitary cells. Although this exper-
imental system does not reflect the physiological situation
because of the absence of pituitary control factors such as
dopamine, it is an appropriate model to study the role of
each compound separately. Our major conclusions are:
(1) T3 uptake into the pituitary is reduced by acute ATP
depletion induced by oligomycin, but not by chronic
energy depletion induced by energy-poor culture con-
ditions; (2) chronic energy depletion is not associated
with changes in TSH release; (3) neither bilirubin nor
biliverdin alter T3 and T4 transport into the pituitary; and
(4) bilirubin does not alter basal or TRH-induced TSH
release.
The effects of fasting on thyroid hormone uptake into
the liver can be investigated in vivo (Van der Heyden et al.
1986, De Jong et al. 1994) or in the perfused liver (De Jong
et al. 1992, 1994), and experiments with hepatocytes can
be performed 4 h after plating (Lim et al. 1993a, b, Vos
et al. 1995), but it is more complicated to study the effects
of fasting on thyroid hormone uptake into the pituitary.
In vivo measurements and adequate perfusion experiments
are excluded for practical reasons, and studies in cultured
cells require at least 2 days to permit attachment of the
cells (Everts et al. 1993, 1994a, 1995a, b); consequently,
effects on the pituitary induced by in vivo treatment may
disappear during prolonged culture of the cells.
As an approach to examining the role of cellular energy
status in T3 transport and TSH release in the pituitary, we
Figure 2 Uptake of [125I]T3 () and [
125I]T4 (M) by anterior
pituitary cells in the presence of bilirubin (a) or biliverdin (b). Cells
were cultured for 3 days at a density of 500 000 cells/well.
Thereafter, culture medium was removed and cells were
preincubated for 30 min in incubation medium containing 0·5%
BSA when [125I]T3 uptake was measured and 0·1% BSA in the
case of [125I]T4, in the absence or presence of bilirubin or
biliverdin (1–200 M). Incubation was started by the addition of
10 l [125I]T3 (50 000 c.p.m.) or [
125I]T4 (100 000 c.p.m.) directly
to the preincubation medium. The 15-min uptake of the two
tracers is expressed per pM free hormone and the concentrations
bilirubin and biliverdin are expressed relative to albumin. Bars
represent the meanS.E. of from five to nine observations from
two experiments for [125I]T4 and three for [
125I]T3 uptake.
Figure 3 Effect of bilirubin (1–200 M) on basal TSH release,
expressed as a percentage of the control value. Anterior pituitary
cells were cultured for 3 days at a density of 400 000 cells/well.
Thereafter, culture medium was removed and cells were pre-
incubated for 2 h in incubation medium containing 0·5% BSA. This
medium was discarded and incubations were performed for 2 h in
medium without or with various concentrations of bilirubin. Bars
show the meanS.E. of nine observations from three experiments.
*P<0·05 compared with no additions.
Energy status, bilirubin and pituitary function · F W J S WASSEN and others 603
www.endocrinology.org Journal of Endocrinology (2000) 165, 599–606
compared the effects of long-term energy deprivation
achieved by culture and incubation of the cells in the
absence of glucose and glutamine with those of acute
energy depletion induced by exposure to oligomycin, an
inhibitor of oxydative phosphorylation. The effect of these
treatments was validated by a 45–50% reduction in cellular
ATP. T3 uptake was not altered under long-term energy-
deprived conditions, but it was significantly reduced by
exposure to oligomycin. Both in cells cultured in the
normal medium and in those cultured in energy-poor
medium, 10 µM unlabelled T3 decreased [
125I]T3 uptake
by around 65%, without affecting the ATP content of the
cells. In previous experiments (Everts et al. 1994b) in
which we studied the effect of 10 µM oligomycin on T3
and tri-iodothyroacetic acid transport, we found that
oligomycin did indeed reduce the cellular ATP level, but
that T3 transport was much more reduced than that of
tri-iodothyroacetic acid transport. As the experimental
conditions differed only with regard to the thyroid
hormone analogue added, it is unlikely that non-specific
toxicity could account for the observed effect. This is in
agreement with our present observation that DNA content
was not altered in presence of oligomycin.
The relation between thyroid hormone uptake and
TSH release during starvation has previously been studied
in vivo: in spite of the decreases in plasma T3 and T4
concentrations, nuclear T3 content in the pituitary was
only slightly reduced and plasma TSH did not increase (St
Germain & Galton 1985). The nuclear-bound T3 in the
pituitary is partly derived from the plasma T3 and partly
from intracellular conversion of T4 to T3 by type II
deiodinase (Van Doorn et al. 1984), and the presence of
type II but not type I deiodinase activity in cultured
anterior pituitary cells has been reported (Everts et al.
1995b). Because type II deiodinase activity was diminished
even in the pituitary of fasted rats (St Germain & Galton
1985), a normal intracellular T3 concentration could be
maintained only if transport of thyroid hormone into the
pituitary were enhanced.
Our experiments did not show a stimulation of T3
transport under energy-poor culture conditions. In view of
the concept that T3 and T4 share a common transporter in
the pituitary (Everts et al. 1994a, 1996), T4 uptake will be
similarly unaffected by long-term energy deprivation. The
observation that T3 transport was not altered complements
our in vitro observation that TSH release remained
the same under long-term energy-deprived conditions.
Conversely, the fact that TSH release during energy-
deprived culture did not change also implies that
the uptake of [125I]T3 into the thyrotrophic cells was
unaltered. This is important to note, because our measure-
ments of [125I]T3 uptake reflect uptake in all cell types of
the pituitary.
In contrast to the effects of long-term energy depri-
vation (3 days), acute energy deprivation (i.e. exposure to
oligomycin for a total of 45 min) resulted in a significant
reduction in T3 uptake, indicating energy-dependence of
the transport process itself. Although it has been ques-
tioned, whether oligomycin can be used to deduce infor-
mation about the ATP-dependence of transport processes
in intact cells (Blondeau et al. 1988), previous studies with
anterior pituitary cells (Everts et al. 1993) have provided
additional evidence for ATP-dependence of the T3 uptake
process by its dependence on the Na+ gradient (Pedersen
& Carafoli 1987) and the temperature. In hepatocytes,
energy-dependence of T3 uptake was demonstrated using
other metabolic inhibitors besides oligomycin (potassium
cyanide and dinitrophenol; Docter & Krenning 1990).
Whereas long-term and acute energy deprivation
resulted in a similar decline in total cellular ATP content,
only acute energy deprivation resulted in a reduction in T3
uptake in pituitary cells. In perfused liver, both acute
Table 2 Effects of bilirubin (5–200 M) on TRH-induced TSH release and cellular TSH
content
TSH content (ng)
Preincubation
medium
Incubation
medium Cells Total§
Incubation conditions
No additions 3·810·65 1·590·24 44·063·13 49·463·45
100 nM TRH 3·150·47 4·830·12* 36·155·82 44·135·82
TRH +5 M bilirubin 3·220·51 4·450·17* 41·364·83 49·034·65
TRH +50 M bilirubin 3·210·52 4·930·09* 41·634·89 49·774·81
TRH +200 M bilirubin 8·150·95* 12·410·72*† 23·942·06* 44·503·52
Data represent the meansS.E. of six observations in two independent experiments. Anterior pituitary
cells (400 000 cells/well) were cultured for 3 days in medium containing 10% fetal calf serum.
Thereafter, cells were preincubated for 2 h in medium containing 0·5% BSA without or with bilirubin
(5–200 M). Incubations were performed either in the absence of any additions or with added TRH
(100 nM) alone, or TRH (100 nM) and bilirubin (5–200 M). TSH was measured in medium and cells by
RIA. §Calculated as the sum of TSH in the two media and the cells. *P<0·05 compared with no
additions; †P<0·05 compared with 100 nM TRH.
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energy depletion (De Jong et al. 1994) and prolonged
fasting (De Jong et al. 1992) resulted in a decrease in
thyroid hormone transport. These observations support the
view that the thyroid hormone uptake mechanism is
energy-dependent both in the pituitary and in the liver,
whereas the long-term regulation of the thyroid hormone
transport capacity in the two organs is different under
conditions associated with a reduction in plasma T3 (see
also Everts et al. 1996).
The concentration of bilirubin is increased in serum of
critically-ill patients and was suggested as one of the factors
causing the low T3 plasma concentrations in these patients,
by the inhibition of T4 transport into the liver (Lim et al.
1993b). In another study, bilirubin and bilirubin deriva-
tives were found to interfere with thyroid hormone
transport in astrocytes (Chantoux et al. 1993). However, in
cultured pituitary cells of the rat, neither bilirubin nor
biliverdin affected T3 or T4 uptake. This again supports
the view of tissue-dependent regulation of thyroid hor-
mone transport in different cell types during NTI, and is in
agreement with the concept of a common carrier for T3
and T4 in the pituitary.
In addition, we questioned whether bilirubin also
could account for the inappropriately low serum TSH
level observed in critically ill patients. The presence of
bilirubin (1–50 µM) did not affect basal or TRH-induced
TSH release; only exposure to the greatest concen-
tration of bilirubin (200 µM) resulted in a significant
increase in basal and TRH-induced TSH release. The
presence of 200 µM bilirubin resulted in a molar ratio of
bilirubin:albumin of 2·4 – a ratio considerably greater than
that measured in normal individuals (0·012) and in patients
with critical illness (0·42) (Lim et al. 1993b). Therefore,
the observed effect of a high bilirubin concentration could
be due to some unspecific effect. Nevertheless, the obser-
vation that bilirubin does not affect pituitary function
although it certainly affects liver function (Lim et al.
1993b) is in accordance with earlier reported differences
concerning the effects of interleukins in liver and pituitary
(Lim et al. 1993b, Wassen et al. 1996).
As the uptake of thyroid hormones is the first step in the
mediation of thyroid hormone action, one could postulate
that other mechanisms are involved in the maintenance of
normal TSH values with low serum T3. Recently, a
differential expression of thyroid hormone receptor iso-
forms has been found in thyrotropin-secreting pituitary
tumours that could account for the altered negative
feedback (Gittoes et al. 1998). This could also be the case
in NTI, although in NTI patients with chronic liver
disease thyroid receptor expression in the liver was not
altered (Chamba et al. 1996). In a more recent paper,
decreased TRH gene expression in the hypothalamus of
patients with NTI was observed (Fliers et al. 1997). This
may in the long run account for a reduction in the TSH
concentration in NTI, but the immediate decline in TSH
seems to occur before the reduction in TRH (Van
Haasteren et al. 1994). Together with a previous report of
a direct effect of cytokines on TSH secretion by pituitary
cells (Wassen et al. 1996), these observations lead to the
conclusion that maintenance of normal TSH concen-
trations in NTI is achieved through an action at several
levels.
In conclusion, the present study shows that thyroid
hormone uptake into cultured anterior pituitary cells is not
affected by long-term energy deprivation, bilirubin or its
precursor biliverdin. These observations lend further sup-
port to the view that thyroid hormone transport into the
pituitary is regulated differently than that in the liver.
However, the fact that T3 uptake is not stimulated under
chronic energy-deprived conditions or by bilirubin cannot
account for the absence of an increase in serum TSH that
is observed during starvation or hyperbilirubinaemia.
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